Fidaxomicin
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Fidaxomicin and local guidelines before prescribing.
Narrow-spectrum macrolide antibiotic
Mechanism
Narrow-spectrum macrolide inhibiting RNA polymerase in C. difficile.
Uses
Clostridioides difficile infection.
Dosing
- First episode: Oral vancomycin 125 mg four times daily for 10 days . Fidaxomicin 200 mg twice daily for 10 days is second-line.
Gastroenterology: Gastroenterology Emergencies (Complete) - Fidaxomicin | 200 mg twice daily for 10 days - second-line, or for recurrence.
Gastroenterology: Gastroenterology Emergencies (Complete) - Second line: Fidaxomicin 200 mg twice daily for 10 days .
Gastroenterology: Bowel Disorders - Fidaxomicin 200 mg twice daily for 10 days | C. difficile second line and early recurrence.
Gastroenterology: Bowel Disorders
1 more dose entries from the chapters
- First episode - oral vancomycin 125 mg four times daily for 10 days ; fidaxomicin 200 mg twice daily for 10 days if vancomycin fails.
ID: Hospital infection, the immunocompromised host, vaccination and public health
Side effects
Nausea, vomiting, abdominal pain; rarely hypersensitivity.
Interactions
P-gp inhibitors (ciclosporin) may raise levels.
Contraindications and cautions
Macrolide allergy
Monitoring
Stool frequency
Pregnancy and breastfeeding
Avoid unless essential
Renal and hepatic impairment
No adjustment
Overdose and reversal
Supportive
Special advice
Preferred first-line; lower recurrence than vancomycin; stop the offending antibiotic where possible.
More from the textbook: uses, cautions and other points
- C. difficile treatment - stop the causing antibiotic and PPIs if possible; oral vancomycin first-line (fidaxomicin for recurrence or high risk of recurrence - NICE NG199); avoid antidiarrhoeals.
Gastroenterology: Anatomy Physiology Pharmacology - Oral vancomycin / fidaxomicin | C. difficile infection.
Gastroenterology: Anatomy Physiology Pharmacology - Within 12 weeks: fidaxomicin.
Gastroenterology: Gastroenterology Emergencies (Complete) - After 12 weeks: vancomycin or fidaxomicin.
Gastroenterology: Gastroenterology Emergencies (Complete) - Recurrence within 12 weeks: Fidaxomicin. After 12 weeks: vancomycin or fidaxomicin.
Gastroenterology: Bowel Disorders - C. difficile: isolate, soap and water, oral vancomycin first line, fidaxomicin second line or for recurrence.
Gastroenterology: Bowel Disorders
Where it is discussed in the book
- Gastroenterology: Anatomy Physiology Pharmacology (2 mentions)
- Gastroenterology: Gastroenterology Emergencies (Complete) (4 mentions)
- Gastroenterology: Bowel Disorders (4 mentions)
- ID: Hospital infection, the immunocompromised host, vaccination and public health (3 mentions)
- Microbiology: Bacteriology - structure, classification and important pathogens (1 mention)